We believe that everyone struggling with lymphedema deserves to

thrive and not just survive

OUR VISION

Our company aims to transform lymphedema treatment for women with a groundbreaking implant technology allowing for seamless integration into patients’ lives, thus increasing patient satisfaction, compliance and quality of life.

For lymphedema patients who cannot tolerate daily compression therapy, our first-in-class implant will provide continuous fluid management without daily intervention, allowing people to return to normal activities that would otherwise be impossible with an external device.

Facts About Lymphedema

Lymphedema may be caused by factors such as radiation from cancer treatment or trauma that impairs lymphatic drainage.

Source : https://surgery.wustl.edu/ask-the-doctors-lymphedema-symptoms-and-causes/
Stage 1 - Latency

No visible swelling but patient may feel fatigue or stiffness due to lymph transport impairment.

Visible swelling (reversible) with pitting edema that resolves with elevation. Patient feels some pain and movements lack fluidity

Visible swelling, that is not reversible without clinical intervention, and non-pitting, fibrotic changes. Patient feels constant low pain and finds daily tasks/routine difficult to perform. Prevalent fatigue experienced plus frequent co-morbidities like fever and other infections/colds.

Severe visible swelling and often skin discoloration/bruising. Patient experiences consistent high pain and severe reduction in ability to move, with simple tasks becoming difficult.

CURRENT TREATMENTS

  • Complete Decongestive Therapy (CDT)
    • Manual Lymphatic drainage techniques such as massaging and physical therapy
    • Compression Therapy with bandaging and wraps
  • Pneumatic Compression Devices (PCDs)

Our Team

Jordan Pollack

CEO

MBA Healthcare Innovation IDC
R&D Engineer at Boston Scientific
CEO of VeinWay

David Knapp

CTO

Board Member at Regenerative Medicine Minnesota,
Former VP R&D Corp Research at Boston Scientific
PhD Chemical Engineering University of Minnesota

Ben Friesem

R&D Advisor

MBA Healthcare Innovation
5 years @ Restore Medical R&D
4 years as CTO of VeinWay

Gregg Pollack

CFO

Former CEO of MorCare LLC
Former CEO of ExtendedCare Solutions
Former CFO of LifeLoop Corp.

Tom Sudow

Executive Chairman

Former Director of BD @ Cleveland Clinic Ventures
Director, Burton D. Morgan Center for
Free Enterprise and Entrepreneurship

Rachel Offenburg

Director of Marketing and
Investor Relations

MBA UVA Darden School of Business
Commercial Strategy Consultant IQVIA
Product Manager at Bio-Rad

Scientific Advisory Board

Brian Berkowitz

PhD

Professor
Weizmann Institute

Lior Heller

MD

Department Chairman of Plastic Surgery
Shamir Medical Center

Dafna Sofrin

Physiotherapist

Physio Clinic Ltd.

Daniel Kedar

MD

Plastic Surgery
Ichilov Tel Aviv Medical Center

Yushi Suzuki

MD

Plastic Surgery
Keio University

Jordan Pollack

Chief Executive Officer

Linkedin

Jordan is a biomedical entrepreneur and engineer with extensive experience in medical device development, innovation, and company leadership. He began his career at Boston Scientific in Minnesota, where he advanced through a rigorous rotational program encompassing roles in Design Assurance, Operations and Manufacturing Engineering, and Process Development. As an R&D engineer, he contributed to the launch of a Class III combination device through FDA and European submissions, pioneered advanced arterial models for stent delivery testing, and conducted in-depth market and product analyses to support device innovation.

Jordan later founded and served as CEO of VeinWay Ltd., a venture focused on solutions for chronic venous occlusions. Over five years, he led the company through successful fundraising rounds totaling $3.2 million, developed early prototypes, and managed a multidisciplinary team that delivered highly impactful compassionate use cases. Jordan is recognized for cultivating a collaborative company culture and guiding his team through both growth and adversity. He is passionate about leadership, learning, and advancing healthcare technologies. Jordan holds bachelor’s and master’s degrees in biomedical engineering from the University of Michigan and an MBA in Healthcare Innovation from the Interdisciplinary College in Herzliya, Israel, completed in 2021.

David Knapp

Chief Technology Officer

Linkedin

Dr. David Knapp is a leader in medical device development and exploratory research, with over 20 years of experience advancing solutions for unmet clinical needs in coronary, cardiovascular, and pulmonary medicine. Known for his relentless pursuit of meaningful innovation, Dr. Knapp has guided teams in the discovery, development, and commercialization of transformative vascular products and has championed collaborative efforts and partnerships to accelerate the translation of novel technologies from the laboratory to patient care. He has held multiple roles at Boston Scientific, including Vice President of Vascular R&D for Peripheral Interventions, where he led the design, development, and launch of multiple technologies that have significantly impacted patient outcomes worldwide.

Dr. Knapp also served as President of the Board for the Boston Scientific Foundation, Executive Sponsor of the Employee Resource Group for Disabilities in Minnesota, and a member of the Boston Scientific Health Advisory Panel. He actively contributes to the broader biomedical ecosystem, holding advisory positions with the University of Michigan, University of Minnesota, and Johns Hopkins University, as well as the Board of Regenerative Medicine Minnesota. Dr. Knapp holds a B.S. in Chemical Engineering from the University of Michigan and a Ph.D. in Chemical Engineering from the University of Minnesota, where he is recognized as a Fellow and Industrial Advisor for the Institute for Engineering in Medicine.

Ben Friesem

R&D Advisor

Linkedin

Ben is an accomplished medical device engineer and innovator with more than 15 years of experience in developing advanced technologies for cardiovascular, spinal, and structural heart applications. He most recently joined Sub-Q Bionics after co-founding VeinWay alongside Jordan and serving as its CTO. Ben’s career encompasses contributions across startup and established environments, including the design and development of implants for minimally invasive spinal orthopedics at Nuvasive, and extensive work on nitinol-based cardiovascular devices and transcatheter delivery systems as the first employee and Senior Development Engineer at Restore Medical. There, he was instrumental in bringing the Contraband System from concept to clinical trial, and he is listed on six issued and pending patents for his inventions.

Ben is recognized for his technical expertise in nitinol and catheter design, as well as his deep knowledge of the medical device start-up landscape. He has led projects from ideation through clinical validation, demonstrating a strong ability to navigate both technical and business challenges in bringing new therapies to market. Ben holds a B.Sc. in Biomedical Engineering from California Polytechnic State University (Cal Poly), an M.Sc. in Biotechnology Engineering from Ben Gurion University, and an MBA in Healthcare Innovation from Reichman University.

Gregg Pollack

Chief Financial Officer

Linkedin

Gregg Pollack is a seasoned healthcare technology executive with broad leadership experience spanning operations, finance, and strategic innovation. He formerly served as President and CEO of MorCare LLC, where he directed all functional areas from Sales and Marketing to IT, Product Management, and Professional Services, delivering vital quality and risk management solutions to hospitals and health systems nationwide. Under his leadership, MorCare advanced initiatives in population health management, bundled payments, and readmission management, supporting organizations across the continuum of care. Gregg also led ExtendedCare Solutions as CEO, developing advanced, video-rich communications platforms to transform virtual care and enhance patient experiences in both acute and post-acute settings.

In addition to his CEO roles, Gregg was Chief Financial Officer at LifeLoop, where he oversaw accounting, finance, forecasting, and revenue operations, furthering the company’s mission to enrich the lives of seniors and support caregivers through technology. Gregg’s career reflects a consistent focus on optimizing value, fostering innovation, and advancing care delivery in healthcare. He holds an MBA in finance and a bachelor’s degree in economics with an accounting concentration from the Wharton School of the University of Pennsylvania and is a CPA and Chartered Global Management Accountant

Tom Sudow

Executive Chairman

Linkedin

Tom Sudow is a veteran leader in high-tech and biosciences with over 30 years of experience driving innovation and business growth across the global healthcare sector. He was Director of Business Development for the Global Cardiovascular Innovation Center, led by Cleveland Clinic, where he helped raise over $1.5 billion for 60 companies—thirty of whose products are now on the market. Tom served as Director of Business Development for Cleveland Clinic Innovations and was a founder of the Beachwood Business Development Center, contributing to over $1 billion in transactions. He has provided expert guidance as an advisor to eHealth Venture, a due diligence committee member for the Akron BioInnovation Fund, and played a major role in building startup and digital health ecosystems nationally and internationally.

Tom is currently Director of the Burton J. Morgan Center for Entrepreneurial Studies at Ashland University, Medical Director for Merchavia, and a Venture Partner for Eliraz Ventures. He is frequently invited to keynote at international conferences and leads seminars on biomedical innovation around the world. Actively engaged in community and professional organizations, Tom has served as president and chair of multiple civic groups, and has received numerous awards for his leadership and achievements. He holds a BA in Political Science and Sociology from Kent State University and a Master of Social Work from the Wurzweiler School of Social Work

Prof. Brian Berkowitz

Scientific Advisor

External-link-square-alt

Dr. Brian Berkowitz is a Full Professor in the Department of Earth and Planetary Sciences at the Weizmann Institute of Science, Israel. He specializes in numerical modeling and laboratory experimentation related to all aspects of fluid dynamics, chemical transport, geochemistry and multiphase phenomena in porous media, particularly in soils, geological formations, and biological media. He has developed a parallel research program applying his expertise to medical research and applications, particularly in the field of endourology. In this context, he uses sophisticated fluid dynamics models and cutting-edge laboratory techniques and methods of physicochemical analysis, to study ureteral stent design and function, kidney stone formation and chemolysis, and clinical treatment of urolithiasis. More recently, Dr. Berkowitz has expanded his research to investigate lymphedema and treatment of swelling. Dr. Berkowitz’s homepage can be accessed here and on Google Scholar.

Dr. Lior Heller

Scientific Advisor

Dr. Lior Heller is a board-certified plastic and general surgeon recognized for his expertise in body contouring, reconstructive surgery following oncologic resection, and aesthetic surgery. He currently serves as the Head of the Department of Plastic Surgery at Assaf Harofeh (Shamir) Medical Center and maintains an active academic and clinical presence both in Israel and internationally. Dr. Heller has held faculty appointments and senior positions at leading institutions, including MD Anderson Cancer Center in Houston and Baylor College of Medicine, where he was responsible for teaching and mentoring fellows, residents, and medical students in plastic and reconstructive surgery. He has organized and taught surgical courses and anatomy workshops, and is renowned for introducing advanced surgical techniques and multidisciplinary approaches to patient care.

Throughout his career, Dr. Heller has been deeply involved in academic leadership, curriculum development, and clinical training, earning the rank of Professor at Sackler School of Medicine, Tel Aviv University. He has published extensively in peer-reviewed journals, contributed chapters to textbooks, and presented research at national and international conferences. His innovative work spans minimally invasive and microsurgical procedures, with a particular focus on complex reconstructions and facial rejuvenation. Dr. Heller received his medical degree from the Hebrew University in Jerusalem and completed residencies in general and plastic surgery, alongside additional advanced fellowships in the United States.

Dr. Dafna Sofrin

Scientific Advisor - Physiotherapist

Dafna Politi Sophrin is an experienced physiotherapist specializing in lymphedema care and rehabilitation. Since 2000, she has owned and directed Physio Clinic Ltd. in Ra’anana, where she leads a multidisciplinary team of physiotherapists with expertise in lymphedema management and neurological rehabilitation. In addition to her clinical work, Dafna oversees the adjustment and sale of orthopedic and lymphedema-related dressings and accessories, supporting comprehensive patient care.

Previously, Dafna managed and worked in a private lymphedema clinic in Holon, and began her career as a physiotherapist at the Geolim Institute of the Clalit Health Fund in Jaffa. Her leadership extends to the professional guidance of colleagues within her clinic. Dafna’s commitment to education and community began early, with military service as a tour guide at the Har Meron Field School for the Society for the Protection of Nature. Dafna holds both a bachelor’s and a master’s degree in physiotherapy from Tel Aviv University.